These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22574675)

  • 1. Cholinergic receptor system as a target for treating alcohol abuse and dependence.
    Rahman S; Prendergast MA
    Recent Pat CNS Drug Discov; 2012 Aug; 7(2):145-50. PubMed ID: 22574675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic receptor modulation to treat alcohol and drug dependence.
    Rahman S; Engleman EA; Bell RL
    Front Neurosci; 2014; 8():426. PubMed ID: 25642160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel medication targets for the treatment of alcoholism: preclinical studies.
    Rezvani AH; Lawrence AJ; Arolfo MP; Levin ED; Overstreet DH
    Recent Pat CNS Drug Discov; 2012 Aug; 7(2):151-62. PubMed ID: 22574676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRs.
    Cippitelli A; Brunori G; Schoch J; Armishaw CJ; Wu J; Zaveri NT; Giulianotti MA; Welmaker GS; Toll L
    Psychopharmacology (Berl); 2018 Jun; 235(6):1745-1757. PubMed ID: 29572652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.
    Chatterjee S; Bartlett SE
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):60-76. PubMed ID: 20201817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Nicotinic Receptor Subtypes in the Behavioral Effects of Nicotinic Drugs in Squirrel Monkeys.
    Withey SL; Doyle MR; Bergman J; Desai RI
    J Pharmacol Exp Ther; 2018 Aug; 366(2):397-409. PubMed ID: 29784663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems.
    Bell RL; Franklin KM; Hauser SR; Zhou FC
    Recent Pat CNS Drug Discov; 2012 Aug; 7(2):93-112. PubMed ID: 22574678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antagonism and tolerance/cross-tolerance among nicotinic acetylcholine receptor agonists: scheduled-controlled responding and hypothermia in C57BL/6J mice.
    de Moura FB; McMahon LR
    Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):240-8. PubMed ID: 26910582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor protection studies comparing recombinant and native nicotinic receptors: Evidence for a subpopulation of mecamylamine-sensitive native alpha3beta4* nicotinic receptors.
    Free RB; Kaser DJ; Boyd RT; McKay DB
    Neurosci Lett; 2006 Jan; 392(1-2):135-9. PubMed ID: 16198480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
    Rollema H; Hurst RS
    Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine-A.
    Touchette JC; Moen JK; Robinson JM; Lee AM
    Addict Biol; 2021 Mar; 26(2):e12908. PubMed ID: 32329567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapies for alcoholism: the old and the new.
    Olive MF
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):2-4. PubMed ID: 20232494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors, decreases ethanol consumption in alcohol-preferring UChB rats.
    Quiroz G; Guerra-Díaz N; Iturriaga-Vásquez P; Rivera-Meza M; Quintanilla ME; Sotomayor-Zárate R
    Behav Brain Res; 2018 Sep; 349():169-176. PubMed ID: 29704599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of nicotinic receptors in alcohol consumption.
    Kamens HM; Flarend G; Horton WJ
    Pharmacol Res; 2023 Apr; 190():106705. PubMed ID: 36813094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting brain nicotinic acetylcholine receptors to treat major depression and co-morbid alcohol or nicotine addiction.
    Rahman S
    CNS Neurol Disord Drug Targets; 2015; 14(5):647-53. PubMed ID: 25921743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependence.
    Leggio L; Cardone S; Ferrulli A; Kenna GA; Diana M; Swift RM; Addolorato G
    Curr Pharm Des; 2010; 16(19):2159-18. PubMed ID: 20482506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of α4β2 nicotinic receptor antagonists and partial-agonists on contextual fear extinction in male C57BL/6 mice.
    Kutlu MG; Tumolo JM; Cann C; Gould TJ
    Psychopharmacology (Berl); 2018 Apr; 235(4):1211-1219. PubMed ID: 29383396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.
    Andreasen JT; Olsen GM; Wiborg O; Redrobe JP
    J Psychopharmacol; 2009 Sep; 23(7):797-804. PubMed ID: 18583432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline in the treatment of alcohol use disorders.
    Erwin BL; Slaton RM
    Ann Pharmacother; 2014 Nov; 48(11):1445-55. PubMed ID: 25095786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal nicotinic acetylcholine receptors are important targets for alcohol reward and dependence.
    Wu J; Gao M; Taylor DH
    Acta Pharmacol Sin; 2014 Mar; 35(3):311-5. PubMed ID: 24464050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.